Status:
SUSPENDED
BE.Amycon Registry UZ Leuven
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Collaborating Sponsors:
Vlaams Instituut voor Biotechnologie
Conditions:
Amyloidosis
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to establish database with (limited) personal and health data of patients diagnosed with amyloidosis (any subtype) in order to get better insights on the diseas...
Detailed Description
With the support of VIB Grand Challenges Program, this project aims to establish the BElgian AMYloidosis CONsortium (BE.AMYCON) by joining forces of VIB researchers, a state-of-the-art diagnostic plat...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Provide consent and sign informed consent form
- Confirmed diagnosis of amyloidosis (any subtype), systemic and/or localised
- Newly diagnosed or in follow-up during the study time-frame (1 JUN 2025 until 31 DEC 2027)
Exclusion
- Not able to provide informed consent
- Not willing to sign informed consent
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2028
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT06998355
Start Date
September 1 2025
End Date
June 1 2028
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven Gasthuisberg
Leuven, Belgium, 3000